(OREX) Orexigen Therapeutics Provides Update on Obesity Drug Candidate

Posted on January 15, 2013 at 17:27 PM EST

Orexigen Therapeutics, Inc. (OREX) recently provided an update on its obesity candidate, Contrave.... Visit StockBlogHub to view complete post.

Related Stocks:

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates